<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02733913</url>
  </required_header>
  <id_info>
    <org_study_id>PVI</org_study_id>
    <nct_id>NCT02733913</nct_id>
  </id_info>
  <brief_title>Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation</brief_title>
  <official_title>Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik f端r Kardiologie, Pneumologie und Angiologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary vein isolation (PVI) has become a standard therapy for atrial fibrillation (AF),
      however, there is still considerable AF recurrence after PVI. Except for PV-left atrium (LA)
      reconnection, the cause of recurrence has been not yet fully clarified.

      The alternation of autonomic tone plays an important role in initiation of paroxysmal AF. It
      was reported that there are multiple gangliated plexus (GP) around pulmonary veins, therefore
      the modulation targeting those GPs, resulting in modulations of cardiac autonomic tone, have
      been conducted. Some study showed the efficacy of GP ablation for AF patients.

      According to the previous reports, heart rate (HR) increased, and heart rate variability
      (HRV) reduced after PVI. These are considered to be due to &quot;autonomic denervation&quot; caused by
      catheter ablation of GP.

      For the best of investigators knowledge, there have been no data on heart rate turbulence
      (HRT) of baroreflex sensitivity (BRS) concerning PVI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence of AF</measure>
    <time_frame>12 months</time_frame>
    <description>Time measured in days to recurrence of AF</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effect of PVI on cardiac autonomic system utilizing HRT measurement</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effect of PVI on cardiac autonomic system utilizing BRS measurement</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>association between measured parameters (HRT, BRS) and the recurrence of AF</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who undergo PVI for paroxysmal AF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who undergo PVI for paroxysmal atrial fibrillation

          -  Patients in sinus rhythm at baseline

        Exclusion Criteria:

          -  prior left atrial Ablation

          -  left atrial diameter &gt;55mm

          -  frequent atrial extrasystole, frequent ventricular Extrasystole

          -  Diabetes Mellitus

          -  sleep apnea syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hisaki Makimoto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonary Disease and Vascular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>D端sseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2016</study_first_submitted>
  <study_first_submitted_qc>April 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>November 9, 2017</last_update_submitted>
  <last_update_submitted_qc>November 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik f端r Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Klinik f端r Kardiologie, Pneumologie und Angiologie</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>pulmonary vein isolation</keyword>
  <keyword>heart rate turbulence</keyword>
  <keyword>baroreflex sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

